BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23582238)

  • 21. Body weight and body composition of depot medroxyprogesterone acetate users.
    Dal'Ava N; Bahamondes L; Bahamondes MV; Bottura BF; Monteiro I
    Contraception; 2014 Aug; 90(2):182-7. PubMed ID: 24780631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of the levonorgestrel intrauterine system among recent postpartum women in Kenya: factors associated with decision-making.
    Hubacher D; Masaba R; Manduku CK; Veena V
    Contraception; 2013 Jul; 88(1):97-102. PubMed ID: 23566383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progestin-only contraceptives: effects on weight.
    Lopez LM; Edelman A; Chen M; Otterness C; Trussell J; Helmerhorst FM
    Cochrane Database Syst Rev; 2013 Jul; 7(7):CD008815. PubMed ID: 23821307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial.
    Beksinska M; Issema R; Beesham I; Lalbahadur T; Thomas K; Morrison C; Hofmeyr GJ; Steyn PS; Mugo N; Palanee-Phillips T; Ahmed K; Nair G; Baeten JM; Smit J
    EClinicalMedicine; 2021 Apr; 34():100800. PubMed ID: 33898953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
    Short M; Dallay D; Omokanye S; Hanisch JU; Inki P
    Eur J Contracept Reprod Health Care; 2012 Feb; 17(1):79-88. PubMed ID: 22200172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of progestin-only long-acting contraception on metabolic markers in obese women.
    Bender NM; Segall-Gutierrez P; Najera SO; Stanczyk FZ; Montoro M; Mishell DR
    Contraception; 2013 Sep; 88(3):418-25. PubMed ID: 23410714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contraceptive method preference and reasons for contraceptive discontinuation among women randomized to intramuscular depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant: Findings from Durban, South Africa.
    Beesham I; Bosman S; Beksinska M; Scoville CW; Smit J; Nanda K
    Contraception; 2022 Apr; 108():37-43. PubMed ID: 34848180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant.
    Deese J; Philip N; Lind M; Ahmed K; Batting J; Beksinska M; Edward VA; Louw CE; Onono M; Palanee-Phillips T; Smit JA; Baeten JM; Donnell D; Mastro TD; Mugo NR; Nanda K; Rees H; Morrison C
    Sex Transm Infect; 2021 Jun; 97(4):249-255. PubMed ID: 33208512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of levonorgestrel 52 mg intrauterine system compared to copper intrauterine device: a population-based cohort study.
    Bosco-Lévy P; Gouverneur A; Langlade C; Miremont G; Pariente A
    Contraception; 2019 Jun; 99(6):345-349. PubMed ID: 30871933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T; Farrant C; Wise MR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does Obesity Influence Body Mass Index Changes in Nulliparous Adolescent Users of Long-Acting Reversible Contraceptives?
    Scott N; Silver EJ; Dodson NA; Coupey SM
    J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):815-820. PubMed ID: 34389461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk.
    Raine-Bennett T; Chandra M; Armstrong MA; Alexeeff S; Lo JC
    Obstet Gynecol; 2019 Sep; 134(3):581-589. PubMed ID: 31403601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
    Lopez LM; Grey TW; Stuebe AM; Chen M; Truitt ST; Gallo MF
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD003988. PubMed ID: 25793657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS; Castro S; Bahamondes MV; Fernandes A; Viola CF; Bahamondes L
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
    Carvalho N; Margatho D; Cursino K; Benetti-Pinto CL; Bahamondes L
    Fertil Steril; 2018 Nov; 110(6):1129-1136. PubMed ID: 30396557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices.
    Heinemann K; Reed S; Moehner S; Minh TD
    Contraception; 2015 Apr; 91(4):280-3. PubMed ID: 25601350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.